Lataa...

Caffeamide 36-13 Regulates the Antidiabetic and Hypolipidemic Signs of High-Fat-Fed Mice on Glucose Transporter 4, AMPK Phosphorylation, and Regulated Hepatic Glucose Production

This study was to investigate the antidiabetic and antihyperlipidemic effects of (E)-3-[3, 4-dihydroxyphenyl-1-(piperidin-1-yl)prop-2-en-1-one] (36-13) (TS), one of caffeic acid amide derivatives, on high-fat (HF-) fed mice. The C57BL/6J mice were randomly divided into the control (CON) group and th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kuo, Yueh-Hsiung, Lin, Cheng-Hsiu, Shih, Chun-Ching
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi Publishing Corporation 2014
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4130186/
https://ncbi.nlm.nih.gov/pubmed/25140189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/821569
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!